Sickle Cell Disease and Fetal Hemoglobin.
作者信息
Rivera Alicia
机构信息
Division of Nephrology, Vascular Biology Research Center, Department of Medicine, Beth Israel Deaconess Medical Center, the Laboratory of Clinical Medicine, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
出版信息
Saudi J Med Med Sci. 2018 Sep-Dec;6(3):131-132. doi: 10.4103/sjmms.sjmms_128_18. Epub 2018 Aug 14.
Abstract
摘要
相似文献
1
Sickle Cell Disease and Fetal Hemoglobin.
Saudi J Med Med Sci. 2018 Sep-Dec;6(3):131-132. doi: 10.4103/sjmms.sjmms_128_18. Epub 2018 Aug 14.
2
Perspective: A Novel Prognostic for Sickle Cell Disease.
Saudi J Med Med Sci. 2018 Sep-Dec;6(3):133-136. doi: 10.4103/sjmms.sjmms_107_18. Epub 2018 Aug 14.
3
Correlation of low levels of nitrite and high levels of fetal hemoglobin in patients with sickle cell disease at baseline.
Rev Bras Hematol Hemoter. 2012;34(4):265-9. doi: 10.5581/1516-8484.20120069.
4
Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
N Engl J Med. 1993 Jan 14;328(2):73-80. doi: 10.1056/NEJM199301143280201.
5
Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea.
PLoS One. 2013;8(2):e55709. doi: 10.1371/journal.pone.0055709. Epub 2013 Feb 7.
6
7
Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea.
N Engl J Med. 1990 Apr 12;322(15):1037-45. doi: 10.1056/NEJM199004123221504.
8
Prevalence of Splenomegaly and Splenic Complications in Adults with Sickle Cell Disease and Its Relation to Fetal Hemoglobin.
Int J Hematol Oncol Stem Cell Res. 2022 Oct 1;16(4):198-208. doi: 10.18502/ijhoscr.v16i4.10877.
9
Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease.
Exp Biol Med (Maywood). 2015 Aug;240(8):1050-64. doi: 10.1177/1535370215596859.
10
Lack of influence of fetal hemoglobin levels or erythrocyte indices on the severity of sickle cell anemia.
J Clin Invest. 1980 Mar;65(3):732-40. doi: 10.1172/JCI109720.
本文引用的文献
1
Perspective: A Novel Prognostic for Sickle Cell Disease.
Saudi J Med Med Sci. 2018 Sep-Dec;6(3):133-136. doi: 10.4103/sjmms.sjmms_107_18. Epub 2018 Aug 14.
2
: a genetic model of fetal hemoglobin in sickle cell disease.
Blood Adv. 2018 Feb 13;2(3):235-239. doi: 10.1182/bloodadvances.2017009811.
3
Biochemical surrogate markers of hemolysis do not correlate with directly measured erythrocyte survival in sickle cell anemia.
Am J Hematol. 2016 Dec;91(12):1195-1201. doi: 10.1002/ajh.24562. Epub 2016 Nov 8.
4
Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions.
PLoS Med. 2013;10(7):e1001484. doi: 10.1371/journal.pmed.1001484. Epub 2013 Jul 16.
5
The relevance of hemoglobin F measurement in the diagnosis of thalassemias and related hemoglobinopathies.
Clin Biochem. 2009 Dec;42(18):1797-801. doi: 10.1016/j.clinbiochem.2009.06.023. Epub 2009 Jul 4.
6
The effect of fetal hemoglobin on the survival characteristics of sickle cells.
Blood. 2006 Aug 1;108(3):1073-6. doi: 10.1182/blood-2005-09-008318.
7
The measurement of accurate fetal hemoglobin and related oxygen saturation by the hemoximeter.
Clin Chim Acta. 2006 Dec;374(1-2):75-80. doi: 10.1016/j.cca.2006.05.042. Epub 2006 Jun 6.
8
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
N Engl J Med. 1995 May 18;332(20):1317-22. doi: 10.1056/NEJM199505183322001.
Zotero 插件